Anixa Biosciences Inc

ANIXNASDAQ · USD
2.93USD+0.08 (+2.81%)
225

Anixa Biosciences Inc (ANIX) Unusual Options Activity Today

ANIX options volume power reached 0.88x on the previous trading day. The highest reading was on the $2.5 CALL expiring 2027-04-16.

Read more

Checking ANIX unusual options activity helps you spot when traders are making outsized bets on Anixa Biosciences Inc before the broader market catches on. Anixa Biosciences Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ANIX unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ANIX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ANIX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ANIX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer.

The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Catalysts rarely arrive without a footprint, and ANIX unusual options activity is often where that footprint shows up first. Our scanner tracks Anixa Biosciences Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ANIX unusual options volume on the call side or chasing put sweeps, Anixa Biosciences Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
2.50—1.001.00374%0540.00%
5.00—0.100.10220%01,0740.00%
7.50—0.250.25400%0190.00%
Puts
2.50—2.002.001,000%0730.00%
5.000.352.501.4332%0330.00%
7.502.856.604.73242%0420.00%

As of September 29, 2026

Spot unusual options activity before it moves

Track ANIX options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial